Le Lézard
Classified in: Health, Business
Subjects: TDS, LIC

PrepMD Partners with MediaSphere and Esteemed Cardiac Experts for Groundbreaking Virtual Device Clinic Leadership Summit


BRAINTREE, Mass., Feb. 21, 2024 /PRNewswire/ -- PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit. Scheduled for March 1st, Friday, from 11 AM to 3 PM EST, this pioneering event will feature distinguished faculty members Aileen Ferrick, Nancy Lee, and Amy Tucker setting a new precedent in cardiac device clinic education and innovation.

A Landmark Educational Event
The summit aims to gather leading experts in cardiac device clinic management for a deep dive into pivotal topics. From the latest Heart Rhythm Society (HRS) 2023 guidelines to tackling harmful practices, embracing best practices, and applying practical solutions, the event promises to elevate patient care and optimize clinic operations.

Comprehensive Curriculum Tailored for Cardiac Device Clinic Professionals
This unique educational experience caters to device clinic managers, staff, and electrophysiologists. It provides an ideal platform for knowledge exchange and strategizing for the successful management of cardiac device clinics. Participants will benefit from a rich curriculum, including:

Distinguished Faculty
The summit is privileged to feature a panel of esteemed faculty members, each recognized for their significant contributions to cardiac care:

Co-Chairs:

Faculty:

Registration Now Open
The Device Clinic Summit is an essential event for all involved in cardiac device clinic management, offering a crucial forum for improving practices and patient care.

For registration and additional details, please visit the official website of the summit, hosted by The Journal of Innovations in Cardiac Rhythm Managementtm.

About PrepMD:
PrepMD is the premier tech-enabled solutions company empowering healthcare providers to achieve exceptional standards of cardiac care. With 15+ years of industry expertise, the company offers a comprehensive portfolio of clinical solutions, featuring exclusive in-clinic staffing services and best-in-class remote monitoring offerings. The company continues to be a leading provider of cardiac training solutions to healthcare providers, corporations, and individuals globally. PrepMD is dedicated to optimizing patient outcomes and driving innovation in cardiac care.

SOURCE PrepMD


These press releases may also interest you

at 04:00
King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have...

at 04:00
IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held from June 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference...

at 03:43
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell analysis of the fully human...

at 03:37
RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024B, the latest version of the company's innovative treatment planning system. The new version comes with automation of important clinical workflows, such as automatic image...

at 03:15
TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer's disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive...

at 03:00
Kedrion Biopharma Inc. announced today that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunoglobulin therapy Yimmugo® in the U.S., following its...



News published on and distributed by: